------ Forwarded Message > From: Lancet <[EMAIL PROTECTED]> > Subject: An important announcement from the Editor of The Lancet Oncology > > Dear Colleague, > > I am writing to you because I thought you would be interested > to receive a free copy of the latest issue of The Lancet > Oncology - the first to include original research. If you click > through the link below, you will be able to access a dynamic, > digital edition of the entire issue. > > Research articles include: > > * Prophylactic quadrivalent human papillomavirus (types 6, 11, > 16, and 18) L1 virus-like particle vaccine in young women: a > randomised double-blind placebo-controlled multicentre phase II > efficacy trial > > Luisa L Villa, et al > > * Gene copy number for epidermal growth factor receptor (EGFR) > and clinical response to antiEGFR treatment in colorectal > cancer: a cohort study > > Mauro Moroni, et al > > * Health-related quality of life in survivors of locally > advanced breast cancer: an international randomised controlled > phase III trial > > Andrew Bottomley, et al, for the European Organisation for > Research and Treatment of Cancer Breast Cancer Group, the > National Cancer Institute of Canada, and Swiss Group for > Clinical Cancer Research > > * Efficacy of tamoxifen and radiotherapy for prevention and > treatment of gynaecomastia and breast pain caused by > bicalutamide in prostate cancer: a randomised controlled trial > > Sisto Perdona, et al > > In addition to these articles, you will also find all the > reviews and opinion The Lancet Oncology is renowned for. > > The digital edition is an exact facsimile of the print copy and > is available for just 7 days. You can turn pages just as you > would with a print edition and even print off the pages for your > own personal use. > > After reading these papers, if you�d like to submit an article > to The Lancet Oncology (Impact Factor of 7.4), our Instructions > for Authors are posted on the journal�s website at > http://oncology.thelancet.com > > Now read your own personal copy of The Lancet Oncology. > http://www.activemag.co.uk/lancet.html > > Best regards, > > Dr David Collingridge > Editor > > PS. Please feel free to forward this email to any of your > colleagues who may also find The Lancet Oncology interesting. > After reading the issue, for a limited period, special > subscription offers are available at www.thelancet.com from as > little as $52/year for online-only access. > >
------------------------ Yahoo! Groups Sponsor --------------------~--> Has someone you know been affected by illness or disease? Network for Good is THE place to support health awareness efforts! http://us.click.yahoo.com/AybhMB/UOnJAA/xGEGAA/8zSolB/TM --------------------------------------------------------------------~-> New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: [email protected] Subscribe: [EMAIL PROTECTED] Unsubscribe: [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED] CML Group Web Site http://groups.yahoo.com/group/CML Yahoo! Groups Links <*> To visit your group on the web, go to: http://groups.yahoo.com/group/CML/ <*> To unsubscribe from this group, send an email to: [EMAIL PROTECTED] <*> Your use of Yahoo! Groups is subject to: http://docs.yahoo.com/info/terms/
